WB (FAQ Protocol), ICC/IF (FAQ Protocol), IP (FAQ Protocol)
Species reactivity
Reacts with: Human
Specificity
Human CYP24A1
Immunogen
E. coli-derived Human CYP24A1 fragment
Preparation
Produced in rabbits immunized with E. coli-derived Human CYP24A1 fragment, and purified by antigen affinity chromatography.
Source
Polyclonal Rabbit IgG
Purification
Protein A & Antigen Affinity
Formulation
PBS, pH7.0 with 0.03% Proclin300
Conjugate
Unconjugated
Form
Liquid
Shipping
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Avoid repeated freeze-thaw cycles.
Anti-CYP24A1 rabbit polyclonal antibody at 1:500 dilution Lane A: A431 Whole Cell Lysate Lysates/proteins at 30 μg per lane. Secondary Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions. Predicted band size:59 kDa Observed band size:59 kDa
Anti-CYP24A1 rabbit polyclonal antibody at 1:500 dilution Lane A: A431 Whole Cell Lysate Lysates/proteins at 30 μg per lane. Secondary Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions. Predicted band size:59 kDa Observed band size:59 kDa
Anti-CYP24A1 rabbit polyclonal antibody at 1:500 dilution Lane A: A431 Whole Cell Lysate Lysates/proteins at 30 μg per lane. Secondary Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions. Predicted band size:59 kDa Observed band size:59 kDa
CYP24A1, encoding the vitamin D-24-hydroxylase, is of major clinical and physiologic importance, serving to regulate the catabolism of 1,25-(OH)2D, the physiologically active vitamin D metabolite. In addition to facilitating catabolism of 1,25-(OH)2D, CYP24A1 also enhances the turnover and elimination of 25-OHD, the abundant precursor metabolite and storage form of the vitamin. CYP24A1, the main enzyme responsible for the degradation of active vitamin D, plays an important role in many cancer related cellular processes. Loss-of-function mutations in the CYP24A1 gene, which encodes the vitamin D-24 hydroxylase, have been recognized as a cause of elevated 1,25-dihydroxy vitamin D concentrations, hypercalcemia, hypercalciuria, nephrocalcinosis, and nephrolithiasis in infants and adults. CYP24A1, is the primary inactivating enzyme for vitamin D, potentially neutralizing the antitumor effects of calcitriol, the active form of vitamin D.
References
Zhu M, et al. (2018) The associations between cyp24a1 polymorphisms and cancer susceptibility: A meta-analysis and trial sequential analysis. Pathol Res Pract 214 (1): 53-63.
Jiráčková J, et al. (2019) Novel cyp24a1 mutation in a young male patient with nephrolithiasis: Case report. Kidney Blood Press Res 44 (4): 870-877.
Gigante M, et al. (2016) Mutational spectrum of cyp24a1 gene in a cohort of italian patients with idiopathic infantile hypercalcemia. Nephron 133 (3): 193-204.
Carpenter TO (2017) Cyp24a1 loss of function: Clinical phenotype of monoallelic and biallelic mutations. J Steroid Biochem Mol Biol 173 337-340.